证券记录 · 已归档季度
RARE
Ultragenyx Pharmaceutical Inc. · Healthcare · Biotechnology
19被追踪持有人
-1Δ持有人
45.29M持有股份
$1.36B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -5.0% ·
股份流向 +8.0% ·
净新建仓位 -10.5%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 477.97K | $7.18M | +1 | −2 |
| Q2 2026 | 97 | -6 | 59.88M | $1.99B | +8 | −14 |
| Q1 2026 | 106 | +4 | 55.54M | $1.16B | +10 | −7 |
| Q4 2025 | 102 | 0 | 62.50M | $1.44B | +1 | n/a |
| Q3 2025 | 19 | -1 | 45.29M | $1.36B | n/a | −2 |
| Q2 2025 | 18 | -1 | 33.50M | $1.22B | n/a | −1 |
| Q1 2025 | 16 | 0 | 17.22M | $623.52M | n/a | n/a |
| Q4 2024 | 16 | +1 | 16.41M | $690.18M | +1 | n/a |
| Q3 2024 | 14 | +2 | 15.84M | $879.45M | +2 | n/a |
| Q2 2024 | 12 | n/a | 15.75M | $647.24M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 10.13M | -0.8% | $304.79M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | JPMorgan Chase ✦ | 8.02M | n/a | $241.33M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 3 | Fidelity (FMR) ✦ | 7.28M | +179.6% | $219.08M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 4 | BlackRock ✦ (被动) | 6.43M | +2.7% | $193.27M | 0.0% | ▲ Add | 2 | SEC ↗ ×16 |
| 5 | State Street Global Advisors ✦ (被动) | 3.69M | +43.5% | $111.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 2.31M | -20.0% | $69.49M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 1.95M | +3.9% | $58.51M | 0.0% | ▲ Add | 6 | SEC ↗ ×6 |
| 8 | Geode Capital Management ✦ (被动) | 1.58M | -7.7% | $47.55M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 910.18K | n/a | $27.38M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 10 | AQR Capital Management ✦ | 746.18K | +195.7% | $22.45M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 11 | Goldman Sachs Group ✦ | 476.94K | n/a | $14.35M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | Adage Capital Partners ✦ | 430.00K | -71.9% | $12.93M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 330.95K | +779.6% | $9.96M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | Two Sigma Investments ✦ | 326.18K | -43.5% | $9.81M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 237.64K | -56.1% | $7.15M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Fisher Asset Management ✦ | 168.08K | -9.5% | $5.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Marshall Wace ✦ | 146.09K | +121.8% | $4.39M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 18 | Millennium Management ✦ | 99.21K | -79.6% | $2.98M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 21.90K | -89.5% | $658,752 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $35.77M | 曾为 0.0% |
| Point72 Asset Management | $18.76M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 293 持有人, 97.86M 股份, $1.96B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 15
Horn Howard
Officer · 7.07K 股 · $107,898
Sep 15
Huizenga Theodore Alan
Officer · 1.28K 股 · $17,410
Sep 03
Huizenga Theodore Alan
Officer · 161 股 · $2,252
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Oct 20
SC 13G: Madison Avenue Partners, LP
Aug 14
SC 13G: RTW INVESTMENTS, LP
Aug 13
SC 13G: AQR CAPITAL MANAGEMENT LLC
Aug 07
SC 13G: STATE STREET CORP
Jul 31
SC 13G: VANGUARD CAPITAL MANAGEMENT LLC
Jul 31
SC 13G/A: VANGUARD PORTFOLIO MANAGEMENT LLC
Jul 30
SC 13G/A: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据